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Tetrahydroquinoline (THQ)-type compounds are a class of potential larvicides 
against mosquitoes. The structure-activity relationships (SAR) of these compounds were 
previously investigated (Sumith et al., Bioorg. Med. Chem. Lett., 2003, 13, 1943-1946), 
and one the of cis-forms (with respect to the configrations of 2-methyl and 4-anilino 
substitutions on the THQ basic structure) was stereoselectively synthesized. However, the 
absolute configrations of C2 and C4 were not determined. In this study, four THQ-type 
compounds with cis configrations were synthesized, and two were submitted for X-ray 
crystal structure analysis. This analysis demonstrated that two enantiomers are packed into 
the crystal form. We synthesized the cis-form of the fluorinated THQ compound, according 
to the published method, and the enantiomers were separated via chiral HPLC. The 
absolute configurations of the enantiomers were determined by X-ray crystallography. Each 
of the enantiomers was tested for activity against mosquito larvae in vivo and competetive 
binding to the ecdysone receptor in vitro. Compared to the (2S, 4R) enantiomer, the (2R, 
4S) enantiomer showed 55 times higher activity in the mosquito larvicidal assay, and 36 
times higher activity in the competetive receptor binding assay.   
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Two major classes of peripheral insect hormones, juvenile hormones (JHs) and 
molting hormones regulate insect growth. The principal molting hormone of insects is 
20-hydroxyecdysone (20E).1 20E and its agonist bind to ecdysone receptors (EcRs) in 
collaboration with the heterodimeric partner, ultraspiracle (USP), and transactivate 
molting-related genes.2 In a few arthropods, other steroid compounds such as ponasterone 
A (PonA), makisterone A, and ecdysone act as molting hormones.3 To date, the primary 
sequences of EcRs and USPs have been identified in various insects.3, 4 Three-dimensional 
structures of the ligand binding domains of EcRs with ponasterone A as the ligand 
molecule were solved by X-ray crystal analysis in three insects: Heliothis virescens,5 
Bemicia tabacii,6 and Tolibolium castaneum.7 The ligand-binding characteristics of 20E, 
which are similar to that of PonA, were also solved in H. virescens.8 The binding sites of 
non-steroidal ecdysone agonists for diacylhydrazine (DAH; BYI06830)5 and two imidazole 
type compounds, BYI08346 and PDB 3IXP,9 were also solved by X-ray analysis. However, 
these structures differ from those of PonA and 20E. 
Compounds that regulate insect molting and metamorphosis are known as insect 
growth regulators (IGRs) or more recently as insect growth disruptors (IGDs), and some of 
these compounds are used as insecticides in the agricultural field.10 IGDs can be classified 
into three major categories, juvenile hormone agonists, chitin synthesis inhibitors and 
molting hormone agonists. Among molting hormone agonists, five diacylhydrazine 
(DAH)-type compounds (tebufenozide, methoxyfenozide, chlomafenozide, fufenozide, and 
halofenozide) are used currently. Most of DAH-type compounds are selectively toxic to 
Lepidoptera, except for halofenozide, which is registered to control both Lepidoptera and 
Coleoptera. However, the binding affinity of halofenozide to coleopteran receptors is not 
stronger than that of other lepidopteran-specific DAHs.11  
 
 
Fig. 1. Structures of ecdysone agonists 
  
 
The high degree of specificity of DAHs against Lepidoptera triggered a search for 
new ecdysone agonists, in both random and rational manners. Although novel non-steroidal 
ecdysone agonists have been reported, none of these has been used commercially.12 Among 
new ecdysone agonists, tetrahydroquinoline (THQ)-type compounds are reported to be 
dipteran-specific,13 particularly to the mosquito EcR.14 These compounds have a unique 
specificity toward mosquitos, which may offer a more selective and environmentally 
friendly pest-management option. Therefore, THQs are promising leads to develop into 
larvicides for mosquito control. A previous structure-activity relationship (SAR) study of 
THQs focused on the optimization of the substituents X and Y, and showed that a 
fluorinated THQ (X=F, Y=4-Cl: THQ in Fig. 1) had the highest ecdysone agonistic activity 


























few THQ analogs according to the published method,13, 15 and compared the binding and 
insecticidal activity of the analogs with the reported activities as shown in Table 1. We also 
reported that compounds lacking the benzene ring of the quinoline structure and the aniline 
moiety, as well as the trans isomer of the 2,4-positions of quinoline moiety were inactive.15  
According to Smith and co-workers13, one of two possible cis-stereoisomers (2R, 
4S) was obtained as a final product by the Doebner-von Miller reaction. However, 
convincing data regarding the stereochemistry of this compound was not reported. In the 
present study, we observed that Smith’s synthesis method did not yield a stereochemically 
pure intermediate. Instead, it yields a racemic mixture via Doebner-von Miller reaction. We 
therefore hypothesized that the THQ reaction mixture prepared by this method also 
contained the (2S, 4R) cis enantiomer. In our preliminary study, we analyzed the X-ray 
crystal structure to determine the absolute configuration of the cis isomers of compounds 1 
(CCDC 984528: Supplement Table 1S) and 2 (CCDC 984529: Supplement Table 1S), in 
which the two enantiomers are packed, respectively. Smith and co-workers reported the 
stereochemistry of THQs based on H-NMR analysis, which is difficult13, 16 without using 
special chiral analysis techniques such as chiral NMR solvent.  
We then asked which enantiomer was biologically active. To determine this, the cis 
product of compound 4 (Y=4-Br) containing two enantiomers [4a (2S, 4R) and 4b (2R, 4S)] 
was prepared according to the reported procedure21, and analyzed by chiral HPLC.22 A 
baseline separation of the two enantiomers was achieved with an amylose-based chiral 
HPLC column,17 packed with a silica gel bound to tris (3,5-dimethylphenylcarbamate) 
derivatives of amylose and eluted with hexane/ethanol (90/10, v/v). The enantiomer excess 
was determined by chiral HPLC and found to be >99%. Each fraction was recrystallized 
from hexane-ethyl acetate and the absolute configurations were determined by X-ray 
crystallography as shown in Fig. 2 with their chemical structures.23 
 
Fig. 2. X-ray structures of enantiomer 4a and 4b. 
 
Crystal data and the data collection parameters for compounds 4a (CCDC 984530) and 4b 




Table 1. X-ray crystallographic data for enantiomers 4a and 4b 
 
 Retension time (HPLC)  
 4.3 min 5.8 min 
 4a 4b 
Empirical formula C23H19BrF2N2O C23H19BrF2N2O 
Formula weight 457.32 457.32 
Crystal system orthorhombic orthorhombic 
Space group  P212121 (#19)  P212121 (#19) 
a (Å) 7.726 (1) 7.7240 (2) 
b (Å) 11.425 (1) 11.423 (3) 
c (Å) 23.284 (2) 23.288 (5) 
V (Å3) 2055.4 (3) 2054.8 (8) 
Z, Dcalc (g/cm3) 4, 1.478 4, 1.478 
F (000) 928.00 928.00 
µ (Cu Kα) (mm-1) 3.024 3.025 
T (K) 243 243 
no. obsd  
(I > 2.00 σ (I))  
3506 3338 
no. parameters 265 265 
R1, wR2 0.040, 0.156 0.043, 0.145 
Flack parameter 0.01(2) 0.01(2) 
GOF 1.300 1.031 
 
The structure-activity relationships for compounds 1–3 were consistent with the 
previously reported structure-activity relationships (SAR).13 The newly synthesized 
compound 4 is three times more toxic against mosquitoes than compound 3, as shown in 
Table 2. The cis-(2R, 4S) enantiomer (4b) showed 55 times higher larvicidal activity 
against mosquito Culex pipiens pallens than the cis-(2S, 4R) enantiomer (4a).24 The 
concentration-response relationships for the larvicidal activity of these enantiomers are 
shown in Fig. 3. Consistently, the active compound 4b had approximately two times higher 
larvicidal activity than the racemic compound 4.  
  
Fig. 3. Concentration-response relationships for 4a (○) and 4b (●) against the 
survival of mosquito larvae. 
 
The EcR-THQ interaction was then investigated to understand the specific larvicidal 
activity of these enantiomers in vitro. We performed a competitive binding assay using 
[3H]PonA as a radioactive ligand for Aedes albopictus (AeAl) cell (NIAS-AeAl-2) 
binding.18,19,25 The results revealed that 4b has a binding affinity for EcR that is 36 times 
more potent than 4a (Table 2). These data indicate that differences in binding affinity 
toward EcR account for the observed larvicidal activity. 
 
Table 2. In vivo and in vitro biological activities of ecdysone agonistsa  
     Compounds 
 No.         (THQ)b 
Larvicidal activity Binding activity 
pLC50 (M) pIC50 (M) 
 X      Y   
1 CH3   4-CH3 5.33 n.d.c 
2 CH3   4-Cl 5.38 5.93 
3 F      4-Cl 6.52 n.d. 
4 F     4-Br 6.92d 6.65 ± 0.13 (n=3) 
4a  F     4-Br 5.65 ± 0.42 (n=2) 5.70 ± 0.16 (n=2) 
4b  F    4-Br 7.40 ± 0.04 (n=2) 7.26 ± 0.04 (n=2) 
Ponasterone A n.d. 9.01 ± 0.01 (n=2)  
Tebufenozide n.d. 7.12 ± 0.03 (n=2) 
a Mean values with standard deviation. Number of experiments. 
b Basic structure is shown in Fig. 1. 
c n.d. not determined. 
d The trans-type compound (2S,4S + 2S,4S) is inactive (<4.52). 
 
 
Figure 4 shows a summary of the SARs of THQs. The methyl group in position 2 is 
required to be in the 2R conformation, and the methyl substituent can be replaced with 
hydrogen. Conversely, the 2S methyl substituent leads to lower activity. This implies that 
the 2S methyl group has a steric collision with the receptor, whereas the 2R methyl group 
and the hydrogen do not. The aniline moiety in position 4 is essential for the larvicidal 
activity as reported previously15 and the 4S chiral conformation is also critical for activity. 
The phenyl group on tetrahydroquinoline ring is also required for activity, but the 
substituent R3 is not essential.13 The larvicidal potency was improved approximately 3 fold 
by changing R4 from 4-chloro to 4-bromo, which can be further optimized in future studies. 
This SAR summary provides valuable information for the molecular design of novel 
ecdysone agonists. 
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Table S1. X-ray crystallographic data for enantiomers 1 (cis) and 2 (cis)  
 1 (cis) 2 (cis) 
Empirical formula C26H28N2O C25H25N2OCl 
Formula weight 384.52 404.94 







a (Å) 9.614 (2) 9.602 (2) 
b (Å) 14.574 (3) 14.447 (3) 
c (Å) 16.551 (3) 16.622 (3) 
α (deg) 93.57 (1) 93.47 (1) 
β (deg) 93.72 (1) 95.23 (1) 
γ (deg) 107.20 (1) 108.37 (1) 
V (Å3) 2202.7 (7) 2169.5 (7) 
Z, Dcalc (g/cm3) 4, 1.159 4, 1.240 
F (000) 824.00 856.00 
µ (Cu Kα) (mm-1) 0.546 1.688 
T (K) 253 253 
No. obsd 
(I > 2.00 σ (I)) 
6216 9700 
No. parameters 639 588 
R1, wR2 0.039, 0.104 0.048, 0.123 




Table S2. X-ray crystallographic data for enantiomers 9a and 9b 
 4.3 min 5.8 min 
 9a 9b 
Empirical formula C23H19BrF2N2O C23H19BrF2N2O 
Formula weight 457.32 457.32 
Crystal system orthorhombic orthorhombic 
Space group  P212121 (#19)  P212121 (#19) 
a (Å) 7.726 (1) 7.7240 (2) 
b (Å) 11.425 (1) 11.423 (3) 
c (Å) 23.284 (2) 23.288 (5) 
V (Å3) 2055.4 (3) 2054.8 (8) 
Z, Dcalc (g/cm3) 4, 1.478 4, 1.478 
F (000) 928.00 928.00 
µ (Cu Kα) (mm-1) 3.024 3.025 
T (K) 243 243 
no. obsd  
(I > 2.00 σ (I))  
3506 3338 
no. parameters 265 265 
R1, wR2 0.040, 0.156 0.043, 0.145 
Flack parameter 0.01(2) 0.01(2) 
GOF 1.300 1.031 
 
 
